Completed PHASE2 INTERVENTIONAL 2-arm NCT01187225

Fibrinogen Concentrate In Children After Cardiac Surgery (FiCCS)

Fibrinogen Concentrate to Treat Bleeding in Children Undergoing Cardiac Surgery With Pump: a Randomised Controlled Clinical Trial

Sponsor: CSL Behring

Conditions Blood Coagulation Disorders Cardiac Surgical Procedures Cryoprecipitate Fibrinogen

Interventions Cryoprecipitate Fibrinogen concentrate

Updated 6 times since 2017 Last updated: Jan 2, 2013 Started: Aug 31, 2010 Primary completion: Jan 31, 2011 Completion: Nov 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01187225, this PHASE2 trial focuses on Blood Coagulation Disorders and Cardiac Surgical Procedures and remains completed. Sponsored by CSL Behring, it has been updated 6 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CSL Behring
University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil